<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2013-2-123-134</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Literature Reviews</subject></subj-group></article-categories><title-group><article-title>ИНДИВИДУАЛЬНАЯ УСТОЙЧИВОСТЬ СТЕРЕОТИПОВ ИММУННОГО РЕАГИРОВАНИЯ И СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ИХ ДИАГНОСТИКИ ПРИ ТРАНСПЛАНТАЦИИ ОРГАНОВ (ИММУНО-ФИЗИОЛОГИЧЕСКИЙ АНАЛИЗ ПРОБЛЕМЫ)</article-title><trans-title-group xml:lang="en"><trans-title>INDIVIDUAL STABILITY OF STEREOTYPES OF IMMUNE REACTING AND MODERN POSSIBILITIES OF THEIR DIAGNOSTIC IN ORGAN TRANSPLANTATION (IMMUNE-PHYSIOLOGICAL ANALYSIS OF A PROBLEM)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онищенко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Onischenko</surname><given-names>N. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артамонов</surname><given-names>С. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Artamonov</surname><given-names>S. D.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крашенинников</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Krasheninnikov</surname><given-names>M. E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Башкина</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bashkina</surname><given-names>L. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никольская</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nicolskaya</surname><given-names>A. O.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Лаборатория биотехнологии стволовых клеток (зав. – проф. Н.А. Онищенко)&#13;
ФГБУ «ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова» Министерства здравоохранения РФ (директор – академик РАМН, проф. С.В. Готье), Москва, Российская Федерация</institution></aff><aff xml:lang="en"><institution>Laboratory stem cells biotechnology (Head – prof. N.A. Onischenko) Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>26</day><month>05</month><year>2014</year></pub-date><volume>15</volume><issue>2</issue><issue-title>ВЕСТНИК ТРАНСПЛАНТОЛОГИИ И ИСКУССТВЕННЫХ ОРГАНОВ том XV No 2–2013</issue-title><fpage>123</fpage><lpage>134</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Онищенко Н.А., Артамонов С.Д., Крашенинников М.Е., Башкина Л.В., Никольская А.О., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Онищенко Н.А., Артамонов С.Д., Крашенинников М.Е., Башкина Л.В., Никольская А.О.</copyright-holder><copyright-holder xml:lang="en">Onischenko N.A., Artamonov S.D., Krasheninnikov M.E., Bashkina L.V., Nicolskaya A.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/124">https://journal.transpl.ru/vtio/article/view/124</self-uri><abstract><p>Авторы обосновывают варианты иммунного реагирования организма при трансплантации органов сущес- твованием индивидуальных специфических программ реагирования на аллоантигены, которые, исполь- зуя естественные активационные и тормозные механизмы, формируют различную степень устойчивости двух физиологических стереотипов «поведения иммунной системы» – эффекторного и толерогенного. Для идентификации индивидуального доминирующего стереотипа иммунного реагирования реципиента на трансплантат и прогнозирования изменений иммунного гомеостаза в организме авторы предлагают использовать показатели реактивности иммунной системы – консервативность и пластичность, которые могут быть выявлены подбором соответствующих биомаркеров. В настоящее время широко использует- ся система маркеров, характеризующих воспалительные реакции (инфекции/воспаления), для выявле- ния отторжения и сопутствующих осложнений. Для прогнозирования индивидуального доминирующего стереотипа реагирования при иммунологически спокойном течении посттрансплантационного периода авторы предлагают изучать систему информационно значимых клеточных маркеров адаптивного имму- нитета и использовать их для формирования комплексных информативных иммуно-клеточных диагнос- тических модулей. </p></abstract><trans-abstract xml:lang="en"><p>The authors prove variants of immune reacting of an human organism in organ transplantation by existence of individual specific programs of reacting on alloantigens which, using natural activatory and inhibitory mecha- nisms, form various degree of stability of two physiological stereotypes of “behavior of immune system” – ef- fectoric and tolerogenic. For identification of an individual predominant stereotype of recipient immune reacting on a graft and for forecasting changes of an immunological homeostasis in a human organism, authors suggest to use indexes of reactance of immune system – conservatism and plasticity which can be taped by selection of the conforming biomarkers. Now the system of markers characterizing inflammatory reactions (infections/ inflammation) for recognition organ rejection and related complications, is widely used. For forecasting of an individual dominant stereotype of reacting in immunologically quiet post-transplant follow-up authors suggest to study a system of informative cellular markers of adaptive immunity and to use them for a formation of complex informative diagnostic immuno-cellular modules. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>стереотипы иммунного ответа</kwd><kwd>трансплантация органов</kwd><kwd>биомаркеры</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stereotypes of the immune reacting</kwd><kwd>organ transplantation</kwd><kwd>biomarkers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sayegh M.H., Carpenter C.B. Transplantation 50 Years Later – Progress, Challenges, and Promises. 2004 // The New England Journal of Medicine. 2004; 26; 351: 2761– 2766. Phillip Scott 2005.</mixed-citation><mixed-citation xml:lang="en">Sayegh M.H., Carpenter C.B. Transplantation 50 Years Later – Progress, Challenges, and Promises. 2004 // The New England Journal of Medicine. 2004; 26; 351: 2761– 2766. Phillip Scott 2005.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tryphonopoulos P., Ruiz P., Weppler D. Long-term fol- low-up of 23 operational tolerant liver transplant reci- pients // Transplantation. 2010 Dec 27; 90 (12): 1556– 1561.</mixed-citation><mixed-citation xml:lang="en">Tryphonopoulos P., Ruiz P., Weppler D. Long-term fol- low-up of 23 operational tolerant liver transplant reci- pients // Transplantation. 2010 Dec 27; 90 (12): 1556– 1561.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hubscher S. What Does the Long-Term Liver Allograft Look Like for the Pediatric Recipient? // Liver Trans- plantation. 2009; 15: S19–S24.</mixed-citation><mixed-citation xml:lang="en">Hubscher S. What Does the Long-Term Liver Allograft Look Like for the Pediatric Recipient? // Liver Trans- plantation. 2009; 15: S19–S24.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Feng S., Ekong U., Lobritto D. Complete Immunosup- pression Withdrawaland Subsequent Allograft Function Among Pediatric Recipientsof Parental Living Donor Liver Transplants // JAMA. January 18, 2012; 307 (3): 283–293.</mixed-citation><mixed-citation xml:lang="en">Feng S., Ekong U., Lobritto D. Complete Immunosup- pression Withdrawaland Subsequent Allograft Function Among Pediatric Recipientsof Parental Living Donor Liver Transplants // JAMA. January 18, 2012; 307 (3): 283–293.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sommerer C., Giese T., Meuer S., Zeier M. Pharmaco- dynamic monitoring of calcineurin inhibitor therapy: Is there a clinical benefit? // Nephro. Dial. Transplant. 2009; 24: 21–27.</mixed-citation><mixed-citation xml:lang="en">Sommerer C., Giese T., Meuer S., Zeier M. Pharmaco- dynamic monitoring of calcineurin inhibitor therapy: Is there a clinical benefit? // Nephro. Dial. Transplant. 2009; 24: 21–27.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nafady-Hego H., Li Y., Ohe H., Zhao X., Satoda N. The Generation of donor-specific CD4+CD25+CD45RA+ naive regulatory T-cells in operationally tolerant patients after pediatric living-donor liver transplantation // Trans-</mixed-citation><mixed-citation xml:lang="en">Nafady-Hego H., Li Y., Ohe H., Zhao X., Satoda N. The Generation of donor-specific CD4+CD25+CD45RA+ naive regulatory T-cells in operationally tolerant patients after pediatric living-donor liver transplantation // Trans-</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">plantation. 2010; 90: 1547–1555.</mixed-citation><mixed-citation xml:lang="en">plantation. 2010; 90: 1547–1555.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Girlanda R., Kirk A.D. Frontiers in Nephrology: Im-</mixed-citation><mixed-citation xml:lang="en">Girlanda R., Kirk A.D. Frontiers in Nephrology: Im-</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">mune Tolerance to Allografts in Humans // J. Am. Soc.</mixed-citation><mixed-citation xml:lang="en">mune Tolerance to Allografts in Humans // J. Am. Soc.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nephrol. 2007; 18: 2242–2251.</mixed-citation><mixed-citation xml:lang="en">Nephrol. 2007; 18: 2242–2251.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Starzl T.E., Lakkis F.G. The Unfinished legacy of liver</mixed-citation><mixed-citation xml:lang="en">Starzl T.E., Lakkis F.G. The Unfinished legacy of liver</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">transplantation // Emphasis on Immunology Hepatology.</mixed-citation><mixed-citation xml:lang="en">transplantation // Emphasis on Immunology Hepatology.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">; 43: 151–163.</mixed-citation><mixed-citation xml:lang="en">; 43: 151–163.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kryzhanovsky G.N. The Basis of common pathophysio-</mixed-citation><mixed-citation xml:lang="en">Kryzhanovsky G.N. The Basis of common pathophysio-</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">logy. M.: Med. inform agency, 2011: 252.</mixed-citation><mixed-citation xml:lang="en">logy. M.: Med. inform agency, 2011: 252.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Jin Bo, Sun Tao, Yu Xiao-Hong The Effects of TLR Ac- tivation on T-Cell Development and Differentiation // Clinical and Developmental Immunology 2012 Volume</mixed-citation><mixed-citation xml:lang="en">Jin Bo, Sun Tao, Yu Xiao-Hong The Effects of TLR Ac- tivation on T-Cell Development and Differentiation // Clinical and Developmental Immunology 2012 Volume</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">, Article ID 836485: 32.</mixed-citation><mixed-citation xml:lang="en">, Article ID 836485: 32.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Alegre M.-L., Goldstein D.R. and Chong A.S. Toll-like</mixed-citation><mixed-citation xml:lang="en">Alegre M.-L., Goldstein D.R. and Chong A.S. Toll-like</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">receptor signaling in transplantation // Curr. Opin. Or-</mixed-citation><mixed-citation xml:lang="en">receptor signaling in transplantation // Curr. Opin. Or-</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">gan. Transplant. 2008 August; 13 (4): 358–365.</mixed-citation><mixed-citation xml:lang="en">gan. Transplant. 2008 August; 13 (4): 358–365.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Louis J., Gumy A., Voigt H. Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th sub- set differentiation // European J. of Dermatology. 2002;</mixed-citation><mixed-citation xml:lang="en">Louis J., Gumy A., Voigt H. Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th sub- set differentiation // European J. of Dermatology. 2002;</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">(4): 316.</mixed-citation><mixed-citation xml:lang="en">(4): 316.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Scott P. Immunologic memory in cutaneous leishmania-</mixed-citation><mixed-citation xml:lang="en">Scott P. Immunologic memory in cutaneous leishmania-</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">sis // Cell. Microbiol. Dec. 2005; 7 (12): 1707–1713.</mixed-citation><mixed-citation xml:lang="en">sis // Cell. Microbiol. Dec. 2005; 7 (12): 1707–1713.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Okwor I., Liu D., Beverley S.M., Uzonn J.E. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10- mediated process // PNAS. 2009 August 18; 106 (33):</mixed-citation><mixed-citation xml:lang="en">Okwor I., Liu D., Beverley S.M., Uzonn J.E. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10- mediated process // PNAS. 2009 August 18; 106 (33):</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">–13956.</mixed-citation><mixed-citation xml:lang="en">–13956.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Colpitts S.L., Scott P. The early generation of a hetero-</mixed-citation><mixed-citation xml:lang="en">Colpitts S.L., Scott P. The early generation of a hetero-</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">geneous CD4+ T-cell response to Leishmania major //</mixed-citation><mixed-citation xml:lang="en">geneous CD4+ T-cell response to Leishmania major //</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">J. Immunol. 2010. August 15; 185 (4): 2416–2423.</mixed-citation><mixed-citation xml:lang="en">J. Immunol. 2010. August 15; 185 (4): 2416–2423.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Van Belle T.L., Coppieter K.T., Von Herrath M.G. Type 1 Diabetes: Etiology, Immunology and Therapeutic Strate-</mixed-citation><mixed-citation xml:lang="en">Van Belle T.L., Coppieter K.T., Von Herrath M.G. Type 1 Diabetes: Etiology, Immunology and Therapeutic Strate-</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">gies // Physiol. Rev. 2011; 91: 79–118.</mixed-citation><mixed-citation xml:lang="en">gies // Physiol. Rev. 2011; 91: 79–118.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Heidt S., San Segundo D., Wood K.J. The impact of</mixed-citation><mixed-citation xml:lang="en">Heidt S., San Segundo D., Wood K.J. The impact of</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">TH17 cells on transplant rejection and theInduction of tolerance // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 456–461.</mixed-citation><mixed-citation xml:lang="en">TH17 cells on transplant rejection and theInduction of tolerance // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 456–461.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Seetharama A., Venkataswarup T., Mohanakumar T. Al loimmunity and autoimmunity in chronic rejection // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 531–536.</mixed-citation><mixed-citation xml:lang="en">Seetharama A., Venkataswarup T., Mohanakumar T. Al loimmunity and autoimmunity in chronic rejection // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 531–536.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Dudai Y. Predicting not to predict too much: how the cellular machinery of memory anticipatesthe uncertain future // Phil. Trans. R. Soc. B. 2009; 364: 1255–1262.</mixed-citation><mixed-citation xml:lang="en">Dudai Y. Predicting not to predict too much: how the cellular machinery of memory anticipatesthe uncertain future // Phil. Trans. R. Soc. B. 2009; 364: 1255–1262.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Gautier S.V. Immunosuppression at transplantation of solid organs. M.: Triada, 2011: 470.</mixed-citation><mixed-citation xml:lang="en">Gautier S.V. Immunosuppression at transplantation of solid organs. M.: Triada, 2011: 470.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zhai Y., Busuttil R.W. and Kupiec-Weglinski J.W. Liver Ischemia and Reperfusion Injury: New Insights into Me- chanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation // Am. J. Transplant. 2011; 11: 1563–1569.</mixed-citation><mixed-citation xml:lang="en">Zhai Y., Busuttil R.W. and Kupiec-Weglinski J.W. Liver Ischemia and Reperfusion Injury: New Insights into Me- chanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation // Am. J. Transplant. 2011; 11: 1563–1569.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mullally A., Ritz J. Hematopoietic stem cell transplanta- tion Beyond HLA: the significance of genomic variation for allogeneic // Blood. 2007, 15 February; 109, Number.</mixed-citation><mixed-citation xml:lang="en">Mullally A., Ritz J. Hematopoietic stem cell transplanta- tion Beyond HLA: the significance of genomic variation for allogeneic // Blood. 2007, 15 February; 109, Number.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Keller M.R., Burlingham W.J. Loss of tolerance to self after transplant Semin Immunopathol. 2011 March; 33 (2): 105–110.</mixed-citation><mixed-citation xml:lang="en">Keller M.R., Burlingham W.J. Loss of tolerance to self after transplant Semin Immunopathol. 2011 March; 33 (2): 105–110.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Ford M.L., Kirk A.D., Larsen C.P. Donor-Reactive T-Cell Stimulation History and Precursor Frequency: Barriers</mixed-citation><mixed-citation xml:lang="en">Ford M.L., Kirk A.D., Larsen C.P. Donor-Reactive T-Cell Stimulation History and Precursor Frequency: Barriers</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">to Tolerance Induction // Transplantation. 2009 May 15;</mixed-citation><mixed-citation xml:lang="en">to Tolerance Induction // Transplantation. 2009 May 15;</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">(9 Suppl): S69–S74.</mixed-citation><mixed-citation xml:lang="en">(9 Suppl): S69–S74.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Krummey S.M., Ford M.L. Heterogeneity within T-Cell</mixed-citation><mixed-citation xml:lang="en">Krummey S.M., Ford M.L. Heterogeneity within T-Cell</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Memory: Implications for Transplant Tolerance // Front</mixed-citation><mixed-citation xml:lang="en">Memory: Implications for Transplant Tolerance // Front</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Immunol. 2012; 3: 36–42.</mixed-citation><mixed-citation xml:lang="en">Immunol. 2012; 3: 36–42.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">D’Orsogna L.J., Roelen D.L., Doxiadis I.I.N.,</mixed-citation><mixed-citation xml:lang="en">D’Orsogna L.J., Roelen D.L., Doxiadis I.I.N.,</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Claas F.H.J. TCR cross-reactivity and allorecognition: new insightsinto the immunogenetics of allorecognition Immunogenetics. 2012; 64: 77–85.</mixed-citation><mixed-citation xml:lang="en">Claas F.H.J. TCR cross-reactivity and allorecognition: new insightsinto the immunogenetics of allorecognition Immunogenetics. 2012; 64: 77–85.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Page A.J., Ford M.L., Kirk A.D. Memory T-Cell-Specific Therapeutics in Organ Transplantation // Curr. Opin. Or- gan. Transplant. 2009 December; 14 (6): 643–649.</mixed-citation><mixed-citation xml:lang="en">Page A.J., Ford M.L., Kirk A.D. Memory T-Cell-Specific Therapeutics in Organ Transplantation // Curr. Opin. Or- gan. Transplant. 2009 December; 14 (6): 643–649.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Augustinea J.J., Siua D.S., Clementeb M.J. Pre-Transp- lant IFN-γ ELISPOTs Are Associated with Post-Transp- lant Renal Function in African American Renal Transp- lant Recipients // Am. J. Transplant. 2005; 5: 1971–1975.</mixed-citation><mixed-citation xml:lang="en">Augustinea J.J., Siua D.S., Clementeb M.J. Pre-Transp- lant IFN-γ ELISPOTs Are Associated with Post-Transp- lant Renal Function in African American Renal Transp- lant Recipients // Am. J. Transplant. 2005; 5: 1971–1975.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Miller D.M., Thornley T.B., Greiner D.L., Rossini A.A. Viral Infection: A Potent Barrier to Transplantation Tole- rance // Clinical and Developmental Immunology, 2008, Article ID 742810, 14 pages doi:10.1155/2008/742810.</mixed-citation><mixed-citation xml:lang="en">Miller D.M., Thornley T.B., Greiner D.L., Rossini A.A. Viral Infection: A Potent Barrier to Transplantation Tole- rance // Clinical and Developmental Immunology, 2008, Article ID 742810, 14 pages doi:10.1155/2008/742810.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Benseler V., Warren A., Vo M. Hepatocyte entry leads to degradation of autoreactive CD8 T cells // PNAS. Octo- ber 4, 2011; 108 (40): 16735–16740.</mixed-citation><mixed-citation xml:lang="en">Benseler V., Warren A., Vo M. Hepatocyte entry leads to degradation of autoreactive CD8 T cells // PNAS. Octo- ber 4, 2011; 108 (40): 16735–16740.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Von Oppen N., Schurich A., Hegenbarth S. Systemic Antigen Cross-Presented by Liver Sinusoidal Endothe- lial Cells Induces Liver-Specific CD8 T-Cell Retention and Tolerization // Hepatology. 2009; 49: 1664–1672.</mixed-citation><mixed-citation xml:lang="en">Von Oppen N., Schurich A., Hegenbarth S. Systemic Antigen Cross-Presented by Liver Sinusoidal Endothe- lial Cells Induces Liver-Specific CD8 T-Cell Retention and Tolerization // Hepatology. 2009; 49: 1664–1672.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Crispe N.I. Liver Antigen-Presenting Cells // Hepatolo- gy. 2011 February; 54 (2): 357–365.</mixed-citation><mixed-citation xml:lang="en">Crispe N.I. Liver Antigen-Presenting Cells // Hepatolo- gy. 2011 February; 54 (2): 357–365.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Jones N.D. Memory T cells: How might they disrupt the induction of tolerance? // Transplantation. 2009 May 15; 87 (9 Suppl): S74–S77.</mixed-citation><mixed-citation xml:lang="en">Jones N.D. Memory T cells: How might they disrupt the induction of tolerance? // Transplantation. 2009 May 15; 87 (9 Suppl): S74–S77.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Pearl J.P., Parris J., Hale D.A. Immunocompetent T- cells with a memory-like phenotype are the dominant- cell type following antibody-mediated T-cell depletion // Am. J. Transplant. 2005; 5: 465–474.</mixed-citation><mixed-citation xml:lang="en">Pearl J.P., Parris J., Hale D.A. Immunocompetent T- cells with a memory-like phenotype are the dominant- cell type following antibody-mediated T-cell depletion // Am. J. Transplant. 2005; 5: 465–474.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Ohe H., Waki K., Yoshitomi M. Factors affecting opera- tional tolerance after pediatric living-donor liver trans- plantation: impact of early post-transplant events and HLA match // European Society for Organ Transplantati- on. 2012; 25: 97–106.</mixed-citation><mixed-citation xml:lang="en">Ohe H., Waki K., Yoshitomi M. Factors affecting opera- tional tolerance after pediatric living-donor liver trans- plantation: impact of early post-transplant events and HLA match // European Society for Organ Transplantati- on. 2012; 25: 97–106.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Kurian S.M., Heilman R., Mondala T.S. Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood. PLoS ONE. July 2009; 4, Issue 7, e6212, 1–11.</mixed-citation><mixed-citation xml:lang="en">Kurian S.M., Heilman R., Mondala T.S. Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood. PLoS ONE. July 2009; 4, Issue 7, e6212, 1–11.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Demetris A.J., Lunz J.G., Randhawa P. Monitoring of human liver and kidney allograft tolerance:a tissue/hi- stopathology perspective 2008 European Society for Or- gan // Transplantation. 2009; 22: 120–141.</mixed-citation><mixed-citation xml:lang="en">Demetris A.J., Lunz J.G., Randhawa P. Monitoring of human liver and kidney allograft tolerance:a tissue/hi- stopathology perspective 2008 European Society for Or- gan // Transplantation. 2009; 22: 120–141.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Reding R., Gras J., Truong D.Q. The Immunological Monitoring of Alloreactive Responses in Liver Trans- plant Recipients: A Review // Liver Transplantation. 2006; 12: 373–383.</mixed-citation><mixed-citation xml:lang="en">Reding R., Gras J., Truong D.Q. The Immunological Monitoring of Alloreactive Responses in Liver Trans- plant Recipients: A Review // Liver Transplantation. 2006; 12: 373–383.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Najafian N., Albin M.J., Newell K.A. How Can We Mea- sure Immunologic Tolerance in Humans? // J. Am. Soc. Nephrol. 2006; 17: 2652–2663.</mixed-citation><mixed-citation xml:lang="en">Najafian N., Albin M.J., Newell K.A. How Can We Mea- sure Immunologic Tolerance in Humans? // J. Am. Soc. Nephrol. 2006; 17: 2652–2663.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Martınez-Llordella M., Puig-Peya I., Orlando G. Mul- tiparameter Immune Profiling of Operational Tolerance in Liver Transplantation // Am. J. Transplant. 2007; 7: 309–319.</mixed-citation><mixed-citation xml:lang="en">Martınez-Llordella M., Puig-Peya I., Orlando G. Mul- tiparameter Immune Profiling of Operational Tolerance in Liver Transplantation // Am. J. Transplant. 2007; 7: 309–319.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Perkins D., Verma M., Park K.J. Advances of genomic science and systems biology in renal transplantation: a review // Semin. Immunopathol. 2011; 33: 211–218.</mixed-citation><mixed-citation xml:lang="en">Perkins D., Verma M., Park K.J. Advances of genomic science and systems biology in renal transplantation: a review // Semin. Immunopathol. 2011; 33: 211–218.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Sigdel T.K., Sarwal M.M. Recent advances in biomarker discovery in solid organ transplant by proteomics // Ex- pert Rev. Proteomics. 2011. December; 8 (6): 705–715.</mixed-citation><mixed-citation xml:lang="en">Sigdel T.K., Sarwal M.M. Recent advances in biomarker discovery in solid organ transplant by proteomics // Ex- pert Rev. Proteomics. 2011. December; 8 (6): 705–715.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Hibi T., Nishida S., Garcia J., Tryphonopoulos P. Ci- trulline Level Is a Potent Indicator of Acute Rejection in the Long Term Following Pediatric Intestinal/Multivis- ceral Transplantation // Am. J. Transplant. 2012; 12: S4. P. 27–32.</mixed-citation><mixed-citation xml:lang="en">Hibi T., Nishida S., Garcia J., Tryphonopoulos P. Ci- trulline Level Is a Potent Indicator of Acute Rejection in the Long Term Following Pediatric Intestinal/Multivis- ceral Transplantation // Am. J. Transplant. 2012; 12: S4. P. 27–32.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Siawaya J.F.D., Roberts T., Babb C. An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays. 2008 PLoS ONE 3 (7): e2535.</mixed-citation><mixed-citation xml:lang="en">Siawaya J.F.D., Roberts T., Babb C. An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays. 2008 PLoS ONE 3 (7): e2535.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Mazariegos G.V. Immunosuppression withdrawal after Liver Transplantation; what are the next steps // Trans- plantation. 2011; 91: 697–699.</mixed-citation><mixed-citation xml:lang="en">Mazariegos G.V. Immunosuppression withdrawal after Liver Transplantation; what are the next steps // Trans- plantation. 2011; 91: 697–699.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Бугров А.В. Клиническое значение лабораторных маркеров sCD30 и РАРР-А при трансплантации серд- ца: Автореф. дис. ... к. м. н. М., 2011: 26.</mixed-citation><mixed-citation xml:lang="en">Бугров А.В. Клиническое значение лабораторных маркеров sCD30 и РАРР-А при трансплантации серд- ца: Автореф. дис. ... к. м. н. М., 2011: 26.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Bougrov A.V. Clinical importance of s CD 30 and PAAP- A markers at heart transplantation: Autroprecis of the- sis ... on cand. med. sci. M., 2011: 26.</mixed-citation><mixed-citation xml:lang="en">Bougrov A.V. Clinical importance of s CD 30 and PAAP- A markers at heart transplantation: Autroprecis of the- sis ... on cand. med. sci. M., 2011: 26.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Орлова О.В. Роль маркеров воспаления, тромбообра- зования, неоангиогенеза и апоптоза в прогнозирова- нии и развитии васкулопатии трансплантированного сердца: Автореф. дис. ... д. м. н. М., 2009: 50.</mixed-citation><mixed-citation xml:lang="en">Орлова О.В. Роль маркеров воспаления, тромбообра- зования, неоангиогенеза и апоптоза в прогнозирова- нии и развитии васкулопатии трансплантированного сердца: Автореф. дис. ... д. м. н. М., 2009: 50.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Orlova O.V. Role of markers of inflammation, trombosis, neoangiogenesis and apoptosis in prognostication of vas- culopatia of transplantated heart: Autoprecis of thesis ... on doct. med. sci. M., 2009: 50.</mixed-citation><mixed-citation xml:lang="en">Orlova O.V. Role of markers of inflammation, trombosis, neoangiogenesis and apoptosis in prognostication of vas- culopatia of transplantated heart: Autoprecis of thesis ... on doct. med. sci. M., 2009: 50.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Пищулин M. Диагностическое и прогностическое значение неоптерина и sCD30 при трансплантации печени: Автореф. дис. ... к. б. н. М., 2012: 25. Pischulina M. Diagnostic and prognostic importance of neopterin and s CD-30 at liver transplantation: Autopre- cis of thesis ... on cand. boil. sci. M., 2012: 25.</mixed-citation><mixed-citation xml:lang="en">Пищулин M. Диагностическое и прогностическое значение неоптерина и sCD30 при трансплантации печени: Автореф. дис. ... к. б. н. М., 2012: 25. Pischulina M. Diagnostic and prognostic importance of neopterin and s CD-30 at liver transplantation: Autopre- cis of thesis ... on cand. boil. sci. M., 2012: 25.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Шевченко О.П., Долгов В.В., Гичкун О.Е., Кунце- вич Н.В., Цирульникова О.М., Готье С.В. Гомоцис- теин при трансплантации печени детям раннего возраста // Вестн. транспл. и искусств. орг. 2012; (4): 44–47.</mixed-citation><mixed-citation xml:lang="en">Шевченко О.П., Долгов В.В., Гичкун О.Е., Кунце- вич Н.В., Цирульникова О.М., Готье С.В. Гомоцис- теин при трансплантации печени детям раннего возраста // Вестн. транспл. и искусств. орг. 2012; (4): 44–47.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko O.P., Dolgov V.V., Gichkun O.E., Kunce- vich N.V., Tsirulnikova O.M., Gautier S.V. Homocysteine after liver transplantation in children // Vestn. transpl. i iskus. org. 2012; (4): 44–47.</mixed-citation><mixed-citation xml:lang="en">Shevchenko O.P., Dolgov V.V., Gichkun O.E., Kunce- vich N.V., Tsirulnikova O.M., Gautier S.V. Homocysteine after liver transplantation in children // Vestn. transpl. i iskus. org. 2012; (4): 44–47.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Шевченко О.П., Цирульникова О.М., Бугров А.В., Лурье Ю.Э., Цирульникова И.Е., Мнацаканян Д.С., Гичкун О.Е., Готье С.В. Инсулиноподобный фактор роста-1 при трансплантации печени детям с врож- денными и наследственными заболеваниями гепа- тобилиарной системы // Вестн. транспл. и искусств. орг. 2012; (1): 50–55.</mixed-citation><mixed-citation xml:lang="en">Шевченко О.П., Цирульникова О.М., Бугров А.В., Лурье Ю.Э., Цирульникова И.Е., Мнацаканян Д.С., Гичкун О.Е., Готье С.В. Инсулиноподобный фактор роста-1 при трансплантации печени детям с врож- денными и наследственными заболеваниями гепа- тобилиарной системы // Вестн. транспл. и искусств. орг. 2012; (1): 50–55.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko O.P., Tsirulnikova O.M., Bougrov A.V., Lou- rie Y.E., Tsirulnikova I.E., Mnatsakanyan D.S., Gich- kun O.E., Gautier S.V. Insulin-like growth factor-1 after orthotopic liver transplantation in children with conge-</mixed-citation><mixed-citation xml:lang="en">Shevchenko O.P., Tsirulnikova O.M., Bougrov A.V., Lou- rie Y.E., Tsirulnikova I.E., Mnatsakanyan D.S., Gich- kun O.E., Gautier S.V. Insulin-like growth factor-1 after orthotopic liver transplantation in children with conge-</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">nital and hereditary diseases of hepatobiliary system //</mixed-citation><mixed-citation xml:lang="en">nital and hereditary diseases of hepatobiliary system //</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Vestn. transpl. i iskus. org. 2012; (1): 50–55.</mixed-citation><mixed-citation xml:lang="en">Vestn. transpl. i iskus. org. 2012; (1): 50–55.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Шевченко О.П., Цирульникова О.М., Гичкун О.Е., Макарова Л.В., Цирульникова И.Е., Ахаладзе Д.Г., Шмерко Н.П., Готье С.В. Прогностическое значение растворимой формы лиганда CD40 при трансплан- тации печени детям с врожденными и наследствен- ными заболеваниями гепатобилиарной системы //</mixed-citation><mixed-citation xml:lang="en">Шевченко О.П., Цирульникова О.М., Гичкун О.Е., Макарова Л.В., Цирульникова И.Е., Ахаладзе Д.Г., Шмерко Н.П., Готье С.В. Прогностическое значение растворимой формы лиганда CD40 при трансплан- тации печени детям с врожденными и наследствен- ными заболеваниями гепатобилиарной системы //</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Вестн. транспл. и искусств. орг. 2012; (2): 15–19.</mixed-citation><mixed-citation xml:lang="en">Вестн. транспл. и искусств. орг. 2012; (2): 15–19.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko O.P., Tsirulnikova O.M., Gichkun O.E., Ma- karova L.V., Tsirulnikova I.E., Akhaladze D.G., Shmer- ko N.P., Gautier S.V. Prognostic value of soluble CD40 ligand after liver transplantation in children with conge- nital and hereditary diseases of hepatobiliary system // Vestn. transpl. i iskus. org. 2012; (2): 15–19.</mixed-citation><mixed-citation xml:lang="en">Shevchenko O.P., Tsirulnikova O.M., Gichkun O.E., Ma- karova L.V., Tsirulnikova I.E., Akhaladze D.G., Shmer- ko N.P., Gautier S.V. Prognostic value of soluble CD40 ligand after liver transplantation in children with conge- nital and hereditary diseases of hepatobiliary system // Vestn. transpl. i iskus. org. 2012; (2): 15–19.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K.H., Oh E.Y., Yung E.S. Evaluation of pre and post transplantation serum interferongamma and soluble CD30 for predicting liver allograft rejection // Transp- lant. Proceed. 2006; 38: 1429–1143.</mixed-citation><mixed-citation xml:lang="en">Kim K.H., Oh E.Y., Yung E.S. Evaluation of pre and post transplantation serum interferongamma and soluble CD30 for predicting liver allograft rejection // Transp- lant. Proceed. 2006; 38: 1429–1143.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Weimer R., Susal C., Iildiz S., Staak A., Pelzl S., Ren- ner F., Dietrich H. Posttransplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens // Am. J. Transp- lant. 2006. Aug; 6 (8): 1865–1874.</mixed-citation><mixed-citation xml:lang="en">Weimer R., Susal C., Iildiz S., Staak A., Pelzl S., Ren- ner F., Dietrich H. Posttransplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens // Am. J. Transp- lant. 2006. Aug; 6 (8): 1865–1874.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Крыжановский Г.Н. Основы общей патофизиологии. М.: Мед. информ. агентство, 2011: 252.</mixed-citation><mixed-citation xml:lang="en">Крыжановский Г.Н. Основы общей патофизиологии. М.: Мед. информ. агентство, 2011: 252.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Kryzhanovsky G.N. Bases of the general pathophysiolo- gy. M.: Med. inform. agency, 2011: 252.</mixed-citation><mixed-citation xml:lang="en">Kryzhanovsky G.N. Bases of the general pathophysiolo- gy. M.: Med. inform. agency, 2011: 252.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Virmani R., Kolodgie F.D., Burke A.P. Atherosclerotic plague progression and vulnezability to rupture: angio- genesis as a source of intraplague hemorrhage // Arterio- scler. thromb. Vasc. Biol. 2005; 25: 2054–2061.</mixed-citation><mixed-citation xml:lang="en">Virmani R., Kolodgie F.D., Burke A.P. Atherosclerotic plague progression and vulnezability to rupture: angio- genesis as a source of intraplague hemorrhage // Arterio- scler. thromb. Vasc. Biol. 2005; 25: 2054–2061.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Adeyi O., Fischer S.E., Guindi M. Liver allograft patho- logy: approach to interpretation of needle biopsies with clinicopathological correlation // J. Clin. Pathol. 2010; 63: 47–74.</mixed-citation><mixed-citation xml:lang="en">Adeyi O., Fischer S.E., Guindi M. Liver allograft patho- logy: approach to interpretation of needle biopsies with clinicopathological correlation // J. Clin. Pathol. 2010; 63: 47–74.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Sallusto F., Lanzavecchia A. Heterogeneity of CD4 me- mory T-cells: Functionalmodules for tailored immuni- ty // Eur. J. Immunol. 2009; 39: 2076–2082.</mixed-citation><mixed-citation xml:lang="en">Sallusto F., Lanzavecchia A. Heterogeneity of CD4 me- mory T-cells: Functionalmodules for tailored immuni- ty // Eur. J. Immunol. 2009; 39: 2076–2082.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Sakaguchi S., Wing K., Miyara M. Regulatory T-cells – a brief history and perspective // Eur. J. Immunol. 2007; 37: S116–123.</mixed-citation><mixed-citation xml:lang="en">Sakaguchi S., Wing K., Miyara M. Regulatory T-cells – a brief history and perspective // Eur. J. Immunol. 2007; 37: S116–123.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Frommer F., Heinen T.J., Wunderlich T. Tolerance wi- thout Clonal Expansion: Self-Antigen-Expressing B- Cells Program Self-Reactive T-Cells for Future Deleti- on // The Journal of Immunology. 2008; 181: 5748–5759.</mixed-citation><mixed-citation xml:lang="en">Frommer F., Heinen T.J., Wunderlich T. Tolerance wi- thout Clonal Expansion: Self-Antigen-Expressing B- Cells Program Self-Reactive T-Cells for Future Deleti- on // The Journal of Immunology. 2008; 181: 5748–5759.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall N.B., Swain S.L. Cytotoxic CD4 T-Cells in An- tiviral Immunity // Journal of Biomedicine and Biotech- nology. 2011; 2011. Article ID 954602: 8.</mixed-citation><mixed-citation xml:lang="en">Marshall N.B., Swain S.L. Cytotoxic CD4 T-Cells in An- tiviral Immunity // Journal of Biomedicine and Biotech- nology. 2011; 2011. Article ID 954602: 8.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Janson P.C., Linton L.B., Bergman E.A., Marits P. Pro- filing of CD4+ T-cells with epigenetic immune lineage analysis // J. Immunol. 2011. Jan 1; 186 (1): 92–102.</mixed-citation><mixed-citation xml:lang="en">Janson P.C., Linton L.B., Bergman E.A., Marits P. Pro- filing of CD4+ T-cells with epigenetic immune lineage analysis // J. Immunol. 2011. Jan 1; 186 (1): 92–102.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Schrage A., Wechsung K., Neumann K. Enhanced T- Cell Transmigration Across the MurineLiver Sinusoidal Endothelium Is Mediated by Transcytosis and Surface Presentation of Chemokines // Hepatology. 2008; 48: 1262–1272.</mixed-citation><mixed-citation xml:lang="en">Schrage A., Wechsung K., Neumann K. Enhanced T- Cell Transmigration Across the MurineLiver Sinusoidal Endothelium Is Mediated by Transcytosis and Surface Presentation of Chemokines // Hepatology. 2008; 48: 1262–1272.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
